Work & Theory on February 9, 2026

Hims cancels plans to sell compounded GLP-1 pill after FDA backlash

HomeUncategorized Hims cancels plans to sell compounded GLP-1 pill after FDA backlash
Uncategorized
1 Min Read

Following escalating legal threats from federal regulators regarding plans to sell an unapproved form of Novo Nordisk’s Wegovy pill, Hims said it “decided to stop offering access” to the treatment.

Continue reading →

Work & Theory on February 9, 2026 Uncategorized

Leave a comment

Your email address will not be published. Required fields are marked *

let’s talk
Get in Touch

Stay up-to-date with the latest releases.

Facebook X-twitter Instagram Linkedin Youtube

© 2025 — AGNO by GT3Themes. All Rights Reserved.

Back to top